| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 3146 |
| 1 | PREDNISONE | 1223 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1166 |
| 3 | MYCOPHENOLATE MOFETIL | 1164 |
| 4 | LENVATINIB | 1128 |
| 5 | PEMBROLIZUMAB | 1072 |
| 6 | OMEPRAZOLE MAGNESIUM | 1008 |
| 7 | TACROLIMUS | 972 |
| 8 | LANSOPRAZOLE | 883 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 811 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENICILLAMINE | 65 | 0.0701 |
| 1 | VOCLOSPORIN | 557 | 0.0569 |
| 2 | ZIV-AFLIBERCEPT | 64 | 0.0491 |
| 3 | LENVATINIB | 1128 | 0.0337 |
| 4 | FRUQUINTINIB | 113 | 0.0287 |
| 5 | BEVACIZUMAB | 3146 | 0.0251 |
| 6 | SPARSENTAN | 166 | 0.0245 |
| 7 | ADEFOVIR DIPIVOXIL | 31 | 0.0244 |
| 8 | RAMUCIRUMAB | 142 | 0.0225 |
| 9 | INTERLEUKIN-10 | 8 | 0.0223 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3373 |
| 1 | Corticosteroid [EPC] | 2789 |
| 2 | Kinase Inhibitor [EPC] | 2082 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1992 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1618 |
| 5 | Proton Pump Inhibitor [EPC] | 1370 |
| 6 | Platinum-based Drug [EPC] | 1203 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1079 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 1033 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 940 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 142 | 0.0225 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1992 | 0.0202 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3373 | 0.0182 |
| 3 | Reducing and Complexing Thiol [EPC] | 43 | 0.0173 |
| 4 | Type I Interferon Receptor Antagonist [EPC] | 25 | 0.0130 |
| 5 | Provitamin D2 Compound [EPC] | 374 | 0.0126 |
| 6 | Tubulin Inhibiting Agent [EPC] | 3 | 0.0103 |
| 7 | Adrenocorticotropic Hormone [EPC] | 9 | 0.0101 |
| 8 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 10 | 0.0092 |
| 9 | Macrolide Antibacterial [EPC] | 9 | 0.0089 |